Details of the Drug
General Information of Drug (ID: DM6HKEC)
| Drug Name |
Nor-binaltorphimine dihydrochloride
|
||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms |
nor-Binaltorphimine dihydrochloride; nor-BNI dihydrochloride; Norbinaltorphimine dihydrochloride; 105618-26-6; EU-0100806; 113158-34-2; CHEMBL2374078; MolPort-003-958-934; Tox21_500806; MFCD00069374; AKOS024457633; LP00806; NCGC00261491-01; NCGC00094139-01; nor-Binaltorphimine dihydrochloride, solid; HY-100903; CS-0020573; N 1771; SR-01000597959; SR-01000075482; SR-01000597959-1; SR-01000075482-1; J-001459
|
||||||||||||||||||||||
| Indication |
|
||||||||||||||||||||||
| Drug Type |
Small molecular drug
|
||||||||||||||||||||||
| Structure |
![]() |
||||||||||||||||||||||
| 3D MOL | 2D MOL | ||||||||||||||||||||||
| #Ro5 Violations (Lipinski): 2 |
Molecular Weight | 734.7 | |||||||||||||||||||||
| Logarithm of the Partition Coefficient | Not Available | ||||||||||||||||||||||
| Rotatable Bond Count | 4 | ||||||||||||||||||||||
| Hydrogen Bond Donor Count | 7 | ||||||||||||||||||||||
| Hydrogen Bond Acceptor Count | 8 | ||||||||||||||||||||||
| Chemical Identifiers |
|
||||||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
| The Studied Disease | Discovery agent | |||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
| Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||


